Search Results - "Veeger, N J"

Refine Results
  1. 1

    High prevalence of peripheral neuropathy in multiple myeloma patients and the impact of vitamin D levels, a cross-sectional study by Oortgiesen, B. E., Kroes, J. A., Scholtens, P., Hoogland, J., Dannenberg - de Keijzer, P., Siemes, C., Jansman, F. G. A., Kibbelaar, R. E., Veeger, N. J. G. M., Hoogendoorn, M., van Roon, E. N.

    Published in Supportive care in cancer (01-01-2022)
    “…Purpose Peripheral neuropathy (PN) is common in patients with multiple myeloma (MM). We hypothesized that the relationship between hypovitaminosis D and PN…”
    Get full text
    Journal Article
  2. 2

    Learning and implementation of TransREctus sheath PrePeritoneal procedure for inguinal hernia repair by Zwols, T. L. R., van der Bilt, A. R. M., Veeger, N. J. G. M., Möllers, M. J. W., Hess, D. A., Brandsma, H. T., Jutte, E., Veldman, P. H. J. M., Eker, H. H., Koning, G. G., Pierie, J. P. E. N.

    “…Purpose The TransREctus sheath PrePeritoneal procedure (TREPP) was introduced as an alternative open and preperitoneal technique for inguinal hernia mesh…”
    Get full text
    Journal Article
  3. 3
  4. 4

    B-type natriuretic peptide and interdialytic fluid retention are independent and incremental predictors of mortality in hemodialysis patients by Westenbrink, B D, Hovinga, T K Kremer, Kloppenburg, W D, Veeger, N J, Janssen, W M T

    Published in Clinical nephrology (01-11-2011)
    “…Management of fluid homeostasis remains a major challenge in hemodialysis patients. We aimed to establish whether the cardiac strain marker B-type natriuretic…”
    Get more information
    Journal Article
  5. 5
  6. 6

    More precise dosing of acenocoumarol for better control in patients aged above 80 years, a randomised controlled pilot study by Piersma-Wichers, M., van Miert, J.H.A., Veeger, N.J.G.M., Kooistra, H.A.M., Meijer, K.

    Published in Thrombosis research (01-12-2020)
    “…Many elderly patients are confined to treatment with vitamin K antagonists (VKA) instead of direct oral anticoagulants (DOACs). However, quality of VKA…”
    Get full text
    Journal Article
  7. 7
  8. 8

    The impact of a male or female thrombotic family history on contraceptive counseling: a cohort study by Vlijmen, E. F. W., Veeger, N. J. G. M., Middeldorp, S., Hamulyák, K., Prins, M. H., Kluin‐Nelemans, H. C., Meijer, K.

    Published in Journal of thrombosis and haemostasis (01-09-2016)
    “…Essentials It is unknown if a male or female thrombotic family history influences risk in female relatives. We assessed thrombotic risk in female relatives of…”
    Get full text
    Journal Article
  9. 9

    Insulin resistance and risk of venous thromboembolism: results of a population‐based cohort study by Van SCHOUWENBURG, I. M., MAHMOODI, B. K., VEEGER, N. J. G. M., BAKKER, S. J. L., KLUIN‐NELEMANS, H. C., MEIJER, K., GANSEVOORT, R. T.

    Published in Journal of thrombosis and haemostasis (01-06-2012)
    “…Background:  Obesity is an established risk factor for venous thromboembolism (VTE), but it is uncertain how this is mediated. Insulin resistance has a central…”
    Get full text
    Journal Article
  10. 10

    Fixed versus variable dose of prothrombin complex concentrate for counteracting vitamin K antagonist therapy by Khorsand, N., Veeger, N. J. G. M., Muller, M., Overdiek, J. W. P. M., Huisman, W., van Hest, R. M., Meijer, K.

    Published in Transfusion medicine (Oxford, England) (01-04-2011)
    “…Background: Although prothrombin complex concentrate (PCC) is often used to counteract vitamin K antagonist (VKA) therapy, evidence regarding the optimal dose…”
    Get full text
    Journal Article
  11. 11

    Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts by van der Helm, L.H, Veeger, N.J.G.M, Kooy, M. van Marwijk, Beeker, A, de Weerdt, O, de Groot, M, Alhan, C, Hoogendoorn, M, Laterveer, L, van de Loosdrecht, A.A, Koedam, J, Vellenga, E, Huls, G

    Published in Leukemia research (01-08-2013)
    “…Abstract The efficacy of azacitidine has been demonstrated in acute myeloid leukemia (AML) patients with 20–30% bone marrow (BM) blasts, but limited data is…”
    Get full text
    Journal Article
  12. 12

    Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitors by Droogsma, Erika, Veeger, N J G M, van Walderveen, P E, Niemarkt, S M, van Asselt, D Z B

    Published in Neurology (23-04-2013)
    “…Pariente et al.[1] concluded that "Treatment gaps do not compromise the outcome of patients treated with cholinesterase inhibitors in a real-life setting."…”
    Get full text
    Journal Article
  13. 13

    Antineutrophil cytoplasmatic antibodies in patients with premature atherosclerosis: prevalence and association with risk factors by VAN HAELST, P. L., ASSELBERGS, F. W., VAN DOORMAAL, J. J., VEEGER, N. J. G. M., MAY, J. F., HOLVOET, P., GANS, R. O. B., TERVAERT, J. W. COHEN

    Published in Journal of internal medicine (01-01-2002)
    “… van Haelst PL, Asselbergs FW, van Doormaal JJ, Veeger NJGM, May JF, Holvoet P, Gans ROB, Cohen Tervaert JW (University Hospital Groningen, Groningen, The…”
    Get full text
    Journal Article
  14. 14

    Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial by Liem, A.H, van Boven, A.J, Veeger, N.J.G.M, Withagen, A.J, Robles de Medina, R.M, Tijssen, J.G.P, van Veldhuisen, D.J

    Published in European heart journal (01-12-2002)
    “…Aims Residual ischaemia following acute myocardial infarction (AMI) is related to an adverse outcome, although the effect of early initiation of statin therapy…”
    Get full text
    Journal Article
  15. 15

    Fetal loss in women with hereditary thrombophilic defects and concomitance of other thrombophilic defects: a retrospective family study by Korteweg, FJ, Folkeringa, N, Brouwer, J-LP, Erwich, JJHM, Holm, JP, van der Meer, J, Veeger, NJGM

    “…Please cite this paper as: Korteweg F, Folkeringa N, Brouwer J, Erwich J, Holm J, van der Meer J, Veeger N. Fetal loss in women with hereditary thrombophilic…”
    Get full text
    Journal Article
  16. 16

    Gender and age-related differences in Burkitt lymphoma – epidemiological and clinical data from The Netherlands by Boerma, E.G., van Imhoff, G.W., Appel, I.M., Veeger, N.J.G.M., Kluin, Ph.M., Kluin-Nelemans, J.C.

    Published in European journal of cancer (1990) (01-12-2004)
    “…Although Burkitt’s lymphoma (BL) is classified as one entity in the World Health Organisation (WHO) classification, we wondered whether BL should not be…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Transfused stored platelets have the same haemostatic function as circulating native platelets by Roeloffzen, W. W. H., Kluin-Nelemans, H. C., Veeger, N. J. G. M., Bosman, L., De Wolf, J. Th. M.

    Published in Vox sanguinis (01-08-2010)
    “…Background and objectives  As thrombelastography® (TEG) measures haemostasis in whole blood, we used this instrument to study whether transfused platelets…”
    Get full text
    Journal Article
  19. 19
  20. 20

    18F-FDG PET/CT in inflammation of unknown origin: a cost-effectiveness pilot-study by Balink, H., Tan, S. S., Veeger, N. J. G. M., Holleman, F., van Eck-Smit, B. L. F., Bennink, R. J., Verberne, H. J.

    “…Purpose Patients with increased inflammatory parameters, nonspecific signs and symptoms without fever and without a diagnosis after a variety of diagnostic…”
    Get full text
    Journal Article